These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 20859541)

  • 1. Role of olmesartan in combination therapy in blood pressure control and vascular function.
    Ferrario CM; Smith RD
    Vasc Health Risk Manag; 2010 Sep; 6():701-9. PubMed ID: 20859541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amlodipine besylate/olmesartan medoximil fixed combination for the treatment of hypertension.
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):887-95. PubMed ID: 19673666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
    Erdine S
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combination.
    Pimenta E; Oparil S
    Vasc Health Risk Manag; 2008; 4(3):653-64. PubMed ID: 18827915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Barrios V; Brommer P; Haag U; Calderón A; Escobar C
    Clin Drug Investig; 2009; 29(7):427-439. PubMed ID: 19499960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of olmesartan, an angiotensin II receptor blocker, and amlodipine, a calcium channel blocker, on Cardio-Ankle Vascular Index (CAVI) in type 2 diabetic patients with hypertension.
    Miyashita Y; Saiki A; Endo K; Ban N; Yamaguchi T; Kawana H; Nagayama D; Ohira M; Oyama T; Shirai K
    J Atheroscler Thromb; 2009 Oct; 16(5):621-6. PubMed ID: 19907103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Triple Combination Therapies Based on Olmesartan: A Personalized Therapeutic Approach to Improve Blood Pressure Control.
    Volpe M; Santolamazza C; Mastromarino V; Coluccia R; Battistoni A; Tocci G
    High Blood Press Cardiovasc Prev; 2017 Sep; 24(3):255-263. PubMed ID: 28608025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARB-based single-pill platform to guide a practical therapeutic approach to hypertensive patients.
    Volpe M; de la Sierra A; Kreutz R; Laurent S; Manolis AJ
    High Blood Press Cardiovasc Prev; 2014 Jun; 21(2):137-47. PubMed ID: 24532183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a stepped-care regimen using olmesartan medoxomil, amlodipine and hydrochlorothiazide in patients with moderate-to-severe hypertension: an open-label, long-term study.
    Volpe M; Miele C; Haag U
    Clin Drug Investig; 2009; 29(6):381-91. PubMed ID: 19432498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive efficacy of olmesartan medoxomil or valsartan in combination with amlodipine: a review of factorial-design studies.
    Ram CV
    Curr Med Res Opin; 2009 Jan; 25(1):177-85. PubMed ID: 19210150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olmesartan/Amlodipine: combination therapy for the treatment of hypertension [corrected].
    Pimenta E
    Adv Ther; 2009 Jan; 26(1):1-11. PubMed ID: 19129998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and tolerability of a fixed-dose combination of olmesartan and amlodipine in clinical practice.
    Bramlage P; Wolf WP; Stuhr T; Fronk EM; Erdlenbruch W; Ketelhut R; Schmieder RE
    Vasc Health Risk Manag; 2010 Sep; 6():803-11. PubMed ID: 20859549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of amlodipine/olmesartan ± hydrochlorothiazide in patients uncontrolled on prior calcium channel blocker or angiotensin II receptor blocker monotherapy.
    Neutel J; Shojaee A; Maa JF
    Adv Ther; 2012 Jun; 29(6):508-23. PubMed ID: 22773358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of olmesartan medoxomil combined with amlodipine in patients with moderate to severe hypertension after amlodipine monotherapy: a randomized, double-blind, parallel-group, multicentre study.
    Volpe M; Brommer P; Haag U; Miele C
    Clin Drug Investig; 2009; 29(1):11-25. PubMed ID: 19067471
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The protective effects of angiotensin II blockade with olmesartan medoxomil on resistance vessel remodeling (The VIOS study): rationale and baseline characteristics.
    Smith RD; Yokoyama H; Averill DB; Cooke L; Brosnihan KB; Schiffrin EL; Ferrario CM
    Am J Cardiovasc Drugs; 2006; 6(5):335-42. PubMed ID: 17083268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of the efficacy of olmesartan/amlodipine vs. perindopril/amlodipine in peripheral blood pressure after missed dose in type 2 diabetes.
    Redon J; Pichler G;
    J Hypertens; 2016 Feb; 34(2):359-67. PubMed ID: 26867060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective systolic blood pressure reduction with olmesartan medoxomil/amlodipine combination therapy: post hoc analysis of data from a randomized, double-blind, parallel-group, multicentre study.
    Mourad JJ; Le Jeune S
    Clin Drug Investig; 2009; 29(6):419-25. PubMed ID: 19432501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Sevikar® compared to the combination of perindopril plus amlodipine on central arterial blood pressure in patients with moderate-to-severe hypertension: Rationale and design of the SEVITENSION study.
    Ruilope LM; Schaefer A
    Contemp Clin Trials; 2011 Sep; 32(5):710-6. PubMed ID: 21586342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for triple fixed-dose combination therapy with an angiotensin II receptor blocker, a calcium channel blocker, and a thiazide diuretic.
    Volpe M; Tocci G
    Vasc Health Risk Manag; 2012; 8():371-80. PubMed ID: 22745561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.
    da Silva PM
    Clin Drug Investig; 2010; 30(9):625-41. PubMed ID: 20626210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.